ambroxol has been researched along with Pain, Chronic in 1 studies
Ambroxol: A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pawlinski, L | 1 |
| Krawczyk, M | 1 |
| Fiema, M | 1 |
| Tobor, E | 1 |
| Kiec-Wilk, B | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Ambroxol on the Inflammatory Markers and Clinical Outcome of Patients With Diabetic Peripheral Neuropathy[NCT05558878] | 80 participants (Anticipated) | Interventional | 2022-10-01 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for ambroxol and Pain, Chronic
| Article | Year |
|---|---|
Dual-action ambroxol in treatment of chronic pain in Gaucher Disease.
Topics: Adult; Ambroxol; Analgesics; Chronic Pain; Female; Gaucher Disease; Humans; Quality of Life | 2020 |